SCHEMBL16250565

SCHEMBL16250565

CC(C)NCCNCc1ccc(Cl)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP2C9 P11712 1/20 0.46
CARM1 Q86X55 1/20 0.40
PRMT6 Q96LA8 1/20 0.40
MAPK1 P28482 2/20 0.38
MAPT P10636 1/20 0.38
CYP3A4 P08684 1/20 0.38
HDAC1 Q13547 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
KCNH2 Q12809 2/20 0.36
TMEM97 Q5BJF2 2/20 0.36
HTR1A P08908 2/20 0.36
HTR1D P28221 2/20 0.36
HTR2A P28223 2/20 0.36
HTR2C P28335 2/20 0.36
HTR7 P34969 2/20 0.36
HTR2B P41595 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10098863 0.79 SIGMAR1 (0.53) CYP1A2CYP2D6CYP2C19CYP2C9CARM1
SCHEMBL22395226 0.78 CYP1A2 (0.50) CYP1A2CYP2D6CYP2C19CYP2C9MAPK1
SCHEMBL19245200 0.76 CARM1 (0.34) CARM1PRMT6HDAC1
SCHEMBL12449774 0.74 TRPV4 (0.38) CYP1A2CYP2D6CYP2C19CYP2C9MAPK1
SCHEMBL530213 0.73 PNMT (0.48) MAPK1MAPTPNMTSIGMAR1
SCHEMBL6418359 0.73 SLC6A4 (0.48) CYP1A2CYP2D6CYP2C19CYP2C9MAPK1
SCHEMBL12312596 0.72 CNR2 (0.44) MAPK1MAPTHDAC1MEN1KMT2A
SCHEMBL7993517 0.71 CXCR4 (0.38) CYP2D6CYP2C19CYP3A4HDAC1
SCHEMBL21066511 0.71 PDCD1 (0.46) CYP1A2CYP2D6CYP2C19CYP2C9MEN1
SCHEMBL11089154 0.70 CYP1A2 (0.66) CYP1A2CYP2D6CYP2C19CYP2C9ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2173723-B3 PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS ARRAY BIOPHARMA INC (US) 2014-11-19 EP disclosed